Tirzepatide - First in a new class of diabetes medication (Part 1)

madman

Super Moderator
Tirzepatide is a new class of medication for t2d that activates GIP and glp1 receptors. Endocrinologist Dr. Thomas Blevins (MD, FACE) from Texas Diabetes and Endocrinology, Austin, TX, presents data and practical information for clinicians.


To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.

Screenshot (18543).png
 


 

Online statistics

Members online
1
Guests online
606
Total visitors
607

Latest posts

Back
Top